289 related articles for article (PubMed ID: 15653418)
1. Longitudinal study in HIV/HCV-coinfected HAART-naive patients and role of HCV genotype.
Caudai C; Pianese M; Zacchini F; Toti M; Zazzi M; Valensin PE
J Clin Virol; 2005 Feb; 32(2):151-5. PubMed ID: 15653418
[TBL] [Abstract][Full Text] [Related]
2. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
[TBL] [Abstract][Full Text] [Related]
3. Evolution of HVR-1 quasispecies after 1-year treatment in HIV/HCV-coinfected patients according to the pattern of response to highly active antiretroviral therapy.
Solmone M; Girardi E; Lalle E; Abbate I; D'Arminio Monforte A; Cozzi-Lepri A; Alessandrini A; Piscopo R; Ebo F; Cosco L; Antonucci G; Ippolito G; Capobianchi MR; ;
Antivir Ther; 2006; 11(1):87-94. PubMed ID: 16518964
[TBL] [Abstract][Full Text] [Related]
4. Liver injury and changes in hepatitis C Virus (HCV) RNA load associated with protease inhibitor-based antiretroviral therapy for treatment-naive HCV-HIV-coinfected patients: lopinavir-ritonavir versus nelfinavir.
Sherman KE; Shire NJ; Cernohous P; Rouster SD; Omachi JH; Brun S; Da Silva B
Clin Infect Dis; 2005 Oct; 41(8):1186-95. PubMed ID: 16163639
[TBL] [Abstract][Full Text] [Related]
5. Evolution of coinfection with human immunodeficiency virus and hepatitis C virus in patients treated with highly active antiretroviral therapy.
Torre D; Tambini R; Cadario F; Barbarini G; Moroni M; Basilico C
Clin Infect Dis; 2001 Nov; 33(9):1579-85. PubMed ID: 11588701
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C plasma viral load is associated with HCV genotype but not with HIV coinfection.
Berger A; von Depka Prondzinski M; Doerr HW; Rabenau H; Weber B
J Med Virol; 1996 Apr; 48(4):339-43. PubMed ID: 8699166
[TBL] [Abstract][Full Text] [Related]
7. CD81 expression in peripheral blood lymphocytes before and after treatment with interferon and ribavirin in HIV/HCV coinfected patients.
Micheloud D; González-Nicolás J; Berenguer J; Lorente R; Miralles P; López JC; Cosín J; Catalán P; Muñoz-Fernández M; Resino S
HIV Med; 2010 Mar; 11(3):161-9. PubMed ID: 19780859
[TBL] [Abstract][Full Text] [Related]
8. Predicting the magnitude of short-term CD4+ T-cell recovery in HIV-infected patients during first-line highly active antiretroviral therapy.
Castagna A; Galli L; Torti C; D'Arminio Monforte A; Mussini C; Antinori A; Cozzi-Lepri A; Ladisa N; De Luca A; Seminari E; Gianotti N; Lazzarin A
Antivir Ther; 2010; 15(2):165-75. PubMed ID: 20386071
[TBL] [Abstract][Full Text] [Related]
9. Intrahepatic HCV RNA loads in 37 HIV-HCV co-infected patients with controlled HIV infection.
Trimoulet P; Neau D; Le Bail B; Rullier A; Winnock M; Galperine T; Legrand E; Schvoerer E; Dupon M; Ragnaud JM; Bioulac-Sage P; Chêne G; Fleury H; Lafon ME
J Med Virol; 2002 Jun; 67(2):143-51. PubMed ID: 11992575
[TBL] [Abstract][Full Text] [Related]
10. A study to investigate the impact of the initiation of highly active antiretroviral therapy on the hepatitis C virus viral load in HIV/HCV-coinfected patients.
Mijch A; Sasadeusz J; Hellard M; Dunne M; McCaw R; Bowden S; Gowans EJ
Antivir Ther; 2005; 10(2):277-84. PubMed ID: 15865222
[TBL] [Abstract][Full Text] [Related]
11. HCV genotype distribution among HIV co-infected individuals in Argentina: relationship with host and viral factors.
Quarleri JF; Bolcic FM; Bouzas MB; Laufer N; Gómez Carrillo M; Mammana L; Kaufman S; Pérez H; Cahn P; Salomon H
Acta Gastroenterol Latinoam; 2007 Jun; 37(2):76-83. PubMed ID: 17684937
[TBL] [Abstract][Full Text] [Related]
12. HIV and hepatitis C coinfection.
Matthews GV; Dore GJ
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B and C viral load changes following initiation of highly active antiretroviral therapy (HAART) in patients with advanced HIV infection.
Asmuth DM; Busch MP; Laycock ME; Mohr BA; Kalish LA; van der Horst CM;
Antiviral Res; 2004 Aug; 63(2):123-31. PubMed ID: 15302141
[TBL] [Abstract][Full Text] [Related]
14. [Effects of double and triple antiretroviral agents on the HCV viral load in patients coinfected with HIV and HCV].
Gavazzi G; Richallet G; Morand P; Bouchard O; Bosseray A; Leclercq P; Micoud M
Pathol Biol (Paris); 1998 Jun; 46(6):412-5. PubMed ID: 9769871
[TBL] [Abstract][Full Text] [Related]
15. [Chronic hepatitis C in patients with HIV/HCV coinfection with high CD4+ lymphocytes count].
Inglot M; Szymczak A; Gładysz A; Małyszczak K; Zalewska M
Przegl Epidemiol; 2007; 61(3):535-43. PubMed ID: 18069391
[TBL] [Abstract][Full Text] [Related]
16. Increase in hepatitis C virus load in hemophiliacs during treatment with highly active antiretroviral therapy.
Ragni MV; Bontempo FA
J Infect Dis; 1999 Dec; 180(6):2027-9. PubMed ID: 10558963
[TBL] [Abstract][Full Text] [Related]
17. Risks of non-accidental mortality by baseline CD4+ T-cell strata in hepatitis-C-positive and -negative individuals initiating highly active antiretroviral therapy.
Moore DM; Hogg RS; Braitstein P; Wood E; Yip B; Montaner JS
Antivir Ther; 2006; 11(1):125-9. PubMed ID: 16518968
[TBL] [Abstract][Full Text] [Related]
18. Influence of hepatitis C genotypes on lipid levels in HIV-positive patients during highly active antiretroviral therapy.
Lapadula G; Torti C; Paraninfo G; Castelnuovo F; Uccelli MC; Costarelli S; Ladisa N; Maserati R; Di Pietro M; De Silvestri A; Tinelli C; Puoti M; Carosi G;
Antivir Ther; 2006; 11(4):521-7. PubMed ID: 16856626
[TBL] [Abstract][Full Text] [Related]
19. Epidemiological, immunological and virological characteristics, and disease progression of HIV-1/HCV-co-infected patients from a southern Brazilian population.
Reiche EM; Bonametti AM; Morimoto HK; Morimoto AA; Wiechemann SL; Matsuo T; Vissoci Reiche F; Vogler IH
Int J Mol Med; 2008 Mar; 21(3):387-95. PubMed ID: 18288387
[TBL] [Abstract][Full Text] [Related]
20. Resolution of HCV infection after highly active antiretroviral therapy in a HIV-HCV coinfected patient.
De Rosa FG; Audagnotto S; Bargiacchi O; Garazzino S; Aguilar Marucco D; Veronese L; Canta F; Bonora S; Sinicco A; Di Perri G
J Infect; 2006 Nov; 53(5):e215-8. PubMed ID: 16549201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
